DOCSLIB.ORG

Suppression of the Invasion and Migration of Cancer Cells by SERPINB Family Genes and Their Derived Peptides

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Suppression of the Invasion and Migration of Cancer Cells by SERPINB Family Genes and Their Derived Peptides 238 ONCOLOGY REPORTS 27: 238-245, 2012 Suppression of the invasion and migration of cancer cells by SERPINB family genes and their derived peptides RUEY-HWANG CHOU1-4, HUI-CHIN WEN1,7, WEI-GUANG LIANG1,5, SHENG-CHIEH LIN1,5, HSIAO-WEI YUAN1, CHENG-WEN WU1,5,6 and WUN-SHAING WAYNE CHANG1 1National Institute of Cancer Research, National Health Research Institutes, Miaoli 35053; 2Center for Molecular Medicine, China Medical University Hospital, Taichung 40402; 3China Medical University, Taichung 40402; 4Department of Biotechnology, Asia University, Taichung 41354; 5College of Life Science, National Tsing Hua University, Hsinchu 30013; 6Institute of Biochemistry and Molecular Biology, National Yang Ming University, Taipei 11221, Taiwan, R.O.C. Received June 28, 2011; Accepted August 17, 2011 DOI: 10.3892/or.2011.1497 Abstract. Apart from SERPINB2 and SERPINB5, the roles SERPINB RCL-peptides may provide a reasonable strategy of the remaining 13 members of the human SERPINB family against lethal cancer metastasis. in cancer metastasis are still unknown. In the present study, we demonstrated that most of these genes are differentially Introduction expressed in tumor tissues compared to matched normal tissues from lung or breast cancer patients. Overexpression of Cancer metastasis is the leading cause of morbidity and each SERPINB gene effectively suppressed the invasiveness mortality in cancer patients. It is a highly complex process, and motility of malignant cancer cells. Among all of the genes, including cell detachment, migration, invasion, circulation in the SERPINB1, SERPINB5 and SERPINB7 genes were more blood vessels, adhesion, colonization at other sites and forma- potent, and the inhibitory effect was further enhanced by tion of secondary tumors (1). Prior to tumor cell detachment co-expression of any two of them. In addition, single treatment from the primary site, which leads to cell migration and inva- of the synthetic peptides corresponding to the P5-P5' sequences sion in the metastasis process, the extracellular matrix (ECM) of the reactive center loop (RCL) of SERPINB1, SERPINB5 microenvironment must be degraded by proteases, such as or SERPINB7 markedly suppressed the invasive and migra- urokinase plasminogen activator (uPA), uPA receptor (uPAR) tory properties of the cancer cells in a dose-dependent manner. and the plasmin network (2,3) and matrix metalloproteinases More significantly, combination treatment of these peptides (MMPs) (4). On the other hand, protease inhibitors negatively in cancer cells further improved the suppressive effect by regulate the proteolysis process in cancer metastasis, e.g. 20-40%. Here, we determined the expression of all SERPINB plasminogen activator inhibitors (PAIs), PAI-1 (SERPINE1) family members in lung and breast cancer patients, and iden- and PAI-2 (SERPINB2) against uPA/uPAR/plasmin network tified those members with potent inhibitory ability toward and the tissue inhibitor of matrix metalloproteinases (TIMPs), invasion and migration, and designed RCL-derived peptides to TIMP-1 to TIMP-4 against MMPs. suppress the malignancy of cancer cells. Forced re-expression Serine protease inhibitors (serpins) regulate many physi- of these anti-invasive SERPINB genes or application of the ological processes, such as blood coagulation, fibrinolysis, inflammation, complement activation and cell migration (5). Based on their phylogenic relationships, the superfamily is divided into 16 different clades (A-P), in which human Correspondence to: Dr W.S.W. Chang, National Institute of Cancer serpins are the first 9 clades (A-I) (6). The clade B serpins Research, National Health Research Institutes, No. 35, Keyan Road, (SERPINB family) is the largest one within the human serpin Zhunan, Miaoli 35053, Taiwan, R.O.C. superfamily. It contains 13 genes located on chromosome E-mail: [email protected] 6p25 (SERPINB1, SERPINB6 and SERPINB9) and 18q21 (the remaining members of the family). Unlike circulating serpins, Dr R.H. Chou, Center for Molecular Medicine, China Medical the SERPINB family genes lack the N and C terminus exten- University Hospital, No. 6, Hsueh-Shih Road, Taichung 40447, Taiwan, R.O.C. sion regions common to other serpins, and lack a secretory E-mail: [email protected] signal peptide; thus they primarily reside within cells (7). Various SERPINB genes have been reported to be cancer- Present address: 7Institute of Cellular and System Medicine, related serpins, but few have been shown to be associated National Health Research Institutes, Taiwan, R.O.C. with cancer invasion and metastasis. Clinical results reveal that a lower level of SERPINB2 expression is associated with Key words: SERPINB family, cancer, migration, invasion poor prognosis and outcome in gastric (8,9), breast (10) and lung cancers (11). Overexpression of SERPINB2 was found CHOU et al: SERPINB GENES AND THEIR DERIVED PEPTIDES SUPPRESS THE MALIGNANCY OF CANCER CELLS 239 Table I. Primers for RT-PCR of SERPINB family genes. Gene symbol Forward primers Reverse primers PCR products (bp) SERPINB1 5'-TCAGCTTGCCCAGGTTCAAACTG-3' 5'-GGATGCTACCTGAGGAATTATGC-3' 300 SERPINB2 5'-GCTGGAGATGTTAGCATGTTCTTG-3' 5'-GGCTTGGTGGAACACTTCAGAAAG-3' 300 SERPINB3 5'-GCGGTCTCGTGCTATCTGG-3' 5'-GTAGGTGATGATCCGAATC-3' 109 SERPINB4 5'-TGGAGCCACGGTCTCTCAG-3' 5'-GGAGATGATAATTCGACTA-3' 115 SERPINB5 5'-CATGGAGGCCACGTTCTGTATG-3' 5'-CCTGGCACCTCTATGGAATCCC-3' 417 SERPINB6 5'-CTCCCGCGGTTTAAACTAGAGG-3' 5'-GCAGAAGAGAATCCCGTTGGTC-3' 300 SERPINB7 5'-GGACCAATCCAAGGCGAATGACC-3' 5'-TAAACAGCGTGGACTGAGGGAGTT-3' 285 SERPINB8 5'-AGCTGGAGGAGAGTTATGACTTG-3' 5'-AGAACCTGCCACAGAACAAGATG-3' 300 SERPINB9 5'-CAAGCCAGACTGTATGAAGAGTAC-3' 5'-AAAGGGTGGTCAGCACAGAACCTG-3' 300 SERPINB10 5'-GCAGACATGATGGAGTTGTATGAAG-3' 5'-GAAGAGGAATGGGTGATTTGCATTG-3' 300 SERPINB11 5'-CGTTTCATGAGTGGACAAGCTCTTC-3' 5'CCTTGAACTGAGCTCTCATTGGTAG-3' 300 SERPINB12 5'-AAGGCACAGATCCTGGAAATGAG-3' 5'-ATTGGGACTTGGAGAGATTCCAG-3' 300 SERPINB13 5'-GCTTCTGCCCAACGACATCG-3' 5'-GCAGCCTCGGTGCCTTCCTC-3' 300 to completely inhibit soluble and cell-surface bound plas- respectively, in RPMI-1640 and MEM α media supplemented minogen activator activity, resulting in the suppression of the with 10% fetal bovine serum (FBS) (Thermo Scientific HyClone, metastasis of melanoma cells in SCID mice (12). SERPINB5 Logan, UT, USA) at 37˚C in a humidified 5% CO2 atmosphere. (MASPIN) has been well studied and was confirmed to be a tumor-suppressor gene, which suppresses tumor growth, Reverse transcription-polymerase chain reaction (RT-PCR). invasion and metastasis in different types of cancers, and has Total RNA was extracted using TRIzol reagent, and cDNA potential therapeutic perspectives (13-15). The squamous- was generated by M-MLV reverse transcriptase according to cell carcinoma antigens (SCCAs), SCCA1 (SERPINB3) and the manufacturer's instructions (Invitrogen Life Technologies, SCCA2 (SERPINB4), have been used as diagnostic markers Carlsbad, CA, USA). The PCR was carried out in a thermocy- for advanced squamous-cell carcinoma. The relative mRNA cler (Biometra, Göttingen, Germany) and conducted in a 25-µl ratio (higher than 0.2) of SERPINB4 over SERPINB3 has reaction volume containing 0.2 µM of each primer, 200 µM been correlated to primary tumor recurrence in head and dNTP, 10 mM Tris-HCl, 50 mM KCl, 1.5 mM MgCl2, 1 U Taq neck squamous-cell carcinoma (16). SERPINB13 was found DNA polymerase (Takara, Kyoto, Japan) and 1 µl cDNA under to be down-regulated in squamous-cell carcinoma of the oral the following conditions: 1 cycle at 94˚C for 2 min; 30 cycles cavity and in squamous-cell carcinoma cell lines of head and at 94˚C for 30 sec, 55˚C for 30 sec, 72˚C for 30 sec; and 1 neck cancer (17), but up-regulated in skin carcinoma (18,19). cycle at 72˚C for 10 min. The primers are listed in Table I. For Recently, decreased expression of SERPIN genes including determining the expression patterns of each SERPINB gene in SERPINB2, SERPINB3, SERPINB4, SERPINB7, SERPINB11, normal and tumor tissues, the human lung matched cDNA pair SERPINB12 and SERPINB13 on chromosome 18q21 has been panel and the human breast matched pair total RNA panel (BD demonstrated in oral squamous-cell carcinomas, while the Clontech, Palo Alto, CA, USA) were used. T/N (tumor vs. matched normal tissues) expression ratio of these SERPIN genes was found to have no significant associa- Cloning of the full-length SERPINB genes and stable transfec- tion with clinicodemographic characteristics (20). tion. The full-length SERPINB genes were amplified by PCR Apart from the previously mentioned members of the from human keratinocyte Matchmaker cDNA Library (BD human SERPINB family, however, whether the remaining Clontech), apart from SERPINB4, SERPINB9, SERPINB11 members, such as SERPINB2 and SERPINB5, are associated and SERPINB12, which were amplified from the MGC: 27150 with cancer and whether they are functionally important in cDNA clone (Invitrogen Life Technologies), HEK-293 cell line cancer metastasis, are still unclear. In the present study, we cDNA, normal lung cDNA (Ambion, Austin, TX, USA), and determined the expression patterns of each SERPINB gene in normal brain cDNA (BD Clontech), respectively. The PCR matched normal and tumor tissues from lung and breast cancer program was as followings: 1 cycle at 94˚C for 2 min; 35 cycles patients, constructed individual SERPINB genes, and screened at 94˚C for 30 sec, 55˚C for 30 sec, 72˚C for 2 min and 1 cycle at their effects on the invasive and migratory properties of malig- 72˚C for 10 min. The cloning sites and primer sequences
Load more

Recommended publications
  • Serpinb1 Controls Encephalitogenic T Helper Cells in Neuroinflammation
    SerpinB1 controls encephalitogenic T helper cells in neuroinflammation Lifei Houa,b,1,2, Deepak A. Raoc,d, Koichi Yukie,f, Jessica Cooleya, Lauren A. Hendersonb,g, A. Helena Jonssonc,d, Dion Kaisermanh, Mark P. Gormanb,i, Peter A. Nigrovicc,d,g, Phillip I. Birdh, Burkhard Becherj, and Eileen Remold-O’Donnella,b,k,2 aThe Program in Cellular and Molecular Medicine, Boston Children’s Hospital, Boston, MA 02115; bDepartment of Pediatrics, Harvard Medical School, Boston, MA 02115; cDivision of Rheumatology, Immunology and Allergy, Brigham and Women’s Hospital, Boston, MA 02115; dDepartment of Medicine, Harvard Medical School, Boston, MA 02115; eDepartment of Anesthesiology, Critical Care and Pain Medicine, Boston Children’s Hospital, Boston, MA 02115; fDepartment of Anesthesiology, Harvard Medical School, Boston, MA 02115; gDivision of Immunology, Boston Children’s Hospital, Boston, MA 02115; hDepartment of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Melbourne, VIC, 3800, Australia; iDepartment of Neurology, Boston Children’s Hospital, Boston, MA 02115; jInflammation Unit, Institute of Experimental Immunology, University of Zurich, CH-8057 Zurich, Switzerland; and kDepartment of Hematology/Oncology, Harvard Medical School, Boston, MA 02115 Edited by Jean Laurent-Casanova, Rockefeller University, New York, NY, and approved August 27, 2019 (received for review April 5, 2019) SerpinB1, a protease inhibitor and neutrophil survival factor, was flammatory tissue injury and neutrophil death, and in naïve mice, recently linked with IL-17–expressing T cells. Here, we show that preserves the bone marrow reserve of mature neutrophils by serpinB1 (Sb1) is dramatically inducedinasubsetofeffector restricting spontaneous cell death mediated by the granule serine CD4 cells in experimental autoimmune encephalomyelitis (EAE).
    [Show full text]
  • ONCOGENOMICS Through the Use of Chemotherapeutic Agents
    Oncogene (2002) 21, 7749 – 7763 ª 2002 Nature Publishing Group All rights reserved 0950 – 9232/02 $25.00 www.nature.com/onc Expression profiling of primary non-small cell lung cancer for target identification Jim Heighway*,1, Teresa Knapp1, Lenetta Boyce1, Shelley Brennand1, John K Field1, Daniel C Betticher2, Daniel Ratschiller2, Mathias Gugger2, Michael Donovan3, Amy Lasek3 and Paula Rickert*,3 1Target Identification Group, Roy Castle International Centre for Lung Cancer Research, University of Liverpool, 200 London Road, Liverpool L3 9TA, UK; 2Institute of Medical Oncology, University of Bern, 3010 Bern, Switzerland; 3Incyte Genomics Inc., 3160 Porter Drive, Palo Alto, California, CA 94304, USA Using a panel of cDNA microarrays comprising 47 650 Introduction transcript elements, we have carried out a dual-channel analysis of gene expression in 39 resected primary The lack of generally effective therapies for lung cancer human non-small cell lung tumours versus normal lung leads to the high mortality rate associated with this tissue. Whilst *11 000 elements were scored as common disease. Recorded 5-year survival figures vary, differentially expressed at least twofold in at least one to some extent perhaps reflecting differences in sample, 96 transcripts were scored as over-represented ascertainment methods, but across Europe are approxi- fourfold or more in at least seven out of 39 tumours mately 10% (Bray et al., 2002). Whilst surgery is an and 30 sequences 16-fold in at least two out of 39 effective strategy for the treatment of localized lesions, tumours, including 24 transcripts in common. Tran- most patients present with overtly or covertly dissemi- scripts (178) were found under-represented fourfold in nated disease.
    [Show full text]
  • Biomarkers of Neonatal Skin Barrier Adaptation Reveal Substantial Differences Compared to Adult Skin
    www.nature.com/pr CLINICAL RESEARCH ARTICLE OPEN Biomarkers of neonatal skin barrier adaptation reveal substantial differences compared to adult skin Marty O. Visscher1,2, Andrew N. Carr3, Jason Winget3, Thomas Huggins3, Charles C. Bascom3, Robert Isfort3, Karen Lammers1 and Vivek Narendran1 BACKGROUND: The objective of this study was to measure skin characteristics in premature (PT), late preterm (LPT), and full-term (FT) neonates compared with adults at two times (T1, T2). METHODS: Skin samples of 61 neonates and 34 adults were analyzed for protein biomarkers, natural moisturizing factor (NMF), and biophysical parameters. Infant groups were: <34 weeks (PT), 34–<37 weeks (LPT), and ≥37 weeks (FT). RESULTS: Forty proteins were differentially expressed in FT infant skin, 38 in LPT infant skin, and 12 in PT infant skin compared with adult skin at T1. At T2, 40 proteins were differentially expressed in FT infants, 38 in LPT infants, and 54 in PT infants compared with adults. All proteins were increased at both times, except TMG3, S100A7, and PEBP1, and decreased in PTs at T1. The proteins are involved in filaggrin processing, protease inhibition/enzyme regulation, and antimicrobial function. Eight proteins were decreased in PT skin compared with FT skin at T1. LPT and FT proteins were generally comparable at both times. Total NMF was lower in infants than adults at T1, but higher in infants at T2. CONCLUSIONS: Neonates respond to the physiological transitions at birth by upregulating processes that drive the production of lower pH of the skin and water-binding NMF components, prevent protease activity leading to desquamation, and increase the 1234567890();,: barrier antimicrobial properties.
    [Show full text]
  • Propranolol-Mediated Attenuation of MMP-9 Excretion in Infants with Hemangiomas
    Supplementary Online Content Thaivalappil S, Bauman N, Saieg A, Movius E, Brown KJ, Preciado D. Propranolol-mediated attenuation of MMP-9 excretion in infants with hemangiomas. JAMA Otolaryngol Head Neck Surg. doi:10.1001/jamaoto.2013.4773 eTable. List of All of the Proteins Identified by Proteomics This supplementary material has been provided by the authors to give readers additional information about their work. © 2013 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 10/01/2021 eTable. List of All of the Proteins Identified by Proteomics Protein Name Prop 12 mo/4 Pred 12 mo/4 Δ Prop to Pred mo mo Myeloperoxidase OS=Homo sapiens GN=MPO 26.00 143.00 ‐117.00 Lactotransferrin OS=Homo sapiens GN=LTF 114.00 205.50 ‐91.50 Matrix metalloproteinase‐9 OS=Homo sapiens GN=MMP9 5.00 36.00 ‐31.00 Neutrophil elastase OS=Homo sapiens GN=ELANE 24.00 48.00 ‐24.00 Bleomycin hydrolase OS=Homo sapiens GN=BLMH 3.00 25.00 ‐22.00 CAP7_HUMAN Azurocidin OS=Homo sapiens GN=AZU1 PE=1 SV=3 4.00 26.00 ‐22.00 S10A8_HUMAN Protein S100‐A8 OS=Homo sapiens GN=S100A8 PE=1 14.67 30.50 ‐15.83 SV=1 IL1F9_HUMAN Interleukin‐1 family member 9 OS=Homo sapiens 1.00 15.00 ‐14.00 GN=IL1F9 PE=1 SV=1 MUC5B_HUMAN Mucin‐5B OS=Homo sapiens GN=MUC5B PE=1 SV=3 2.00 14.00 ‐12.00 MUC4_HUMAN Mucin‐4 OS=Homo sapiens GN=MUC4 PE=1 SV=3 1.00 12.00 ‐11.00 HRG_HUMAN Histidine‐rich glycoprotein OS=Homo sapiens GN=HRG 1.00 12.00 ‐11.00 PE=1 SV=1 TKT_HUMAN Transketolase OS=Homo sapiens GN=TKT PE=1 SV=3 17.00 28.00 ‐11.00 CATG_HUMAN Cathepsin G OS=Homo
    [Show full text]
  • A Truncating Mutation in SERPINB6 Is Associated with Autosomal-Recessive Nonsyndromic Sensorineural Hearing Loss
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector REPORT A Truncating Mutation in SERPINB6 Is Associated with Autosomal-Recessive Nonsyndromic Sensorineural Hearing Loss Aslı Sırmacı,1,2 Seyra Erbek,3 Justin Price,1,2 Mingqian Huang,4 Duygu Duman,5 F. Basxak Cengiz,5 Gu¨ney Bademci,1,2 Suna Tokgo¨z-Yılmaz,5 Burcu Hisxmi,5 Hilal O¨ zdag˘,6 Banu O¨ ztu¨rk,7 Sevsen Kulaksızog˘lu,8 Erkan Yıldırım,9 Haris Kokotas,10 Maria Grigoriadou,10 Michael B. Petersen,10 Hashem Shahin,11 Moien Kanaan,11 Mary-Claire King,12 Zheng-Yi Chen,4 Susan H. Blanton,1,2 Xue Z. Liu,2,13 Stephan Zuchner,1,2 Nejat Akar,5 and Mustafa Tekin1,2,* More than 270 million people worldwide have hearing loss that affects normal communication. Although astonishing progress has been made in the identification of more than 50 genes for deafness during the past decade, the majority of deafness genes are yet to be identified. In this study, we mapped a previously unknown autosomal-recessive nonsyndromic sensorineural hearing loss locus (DFNB91) to chromo- some 6p25 in a consanguineous Turkish family. The degree of hearing loss was moderate to severe in affected individuals. We subsequently identified a nonsense mutation (p.E245X) in SERPINB6, which is located within the linkage interval for DFNB91 and encodes for an intra- cellular protease inhibitor. The p.E245X mutation cosegregated in the family as a completely penetrant autosomal-recessive trait and was absent in 300 Turkish controls. The mRNA expression of SERPINB6 was reduced and production of protein was absent in the peripheral leukocytes of homozygotes, suggesting that the hearing loss is due to loss of function of SERPINB6.
    [Show full text]
  • Epigenetic Suppression of SERPINB1 Promotes Inflammation-Mediated Prostate Cancer Progression
    Published OnlineFirst January 4, 2019; DOI: 10.1158/1541-7786.MCR-18-0638 Cancer Genes and Networks Molecular Cancer Research Epigenetic Suppression of SERPINB1 Promotes Inflammation-Mediated Prostate Cancer Progression Irina Lerman1, Xiaoting Ma1, Christina Seger1, Aerken Maolake2, Maria de la Luz Garcia-Hernandez3, Javier Rangel-Moreno3, Jessica Ackerman4, Kent L. Nastiuk2, Martha Susiarjo5, and Stephen R. Hammes1 Abstract Granulocytic myeloid infiltration and resultant enhanced tatic epithelial cells (RWPE-1) increases proliferation, neutrophil elastase (NE) activity is associated with poor out- decreases apoptosis, and stimulates expression of epithelial- comes in numerous malignancies. We recently showed that NE to-mesenchymal transition markers. In contrast, stable SER- expression and activity from infiltrating myeloid cells was high PINB1 expression in normally low-expressing prostate cancer in human prostate cancer xenografts and mouse Pten-null cells (C4-2) reduces xenograft growth in vivo. Finally, EZH2- prostate tumors. We further demonstrated that NE directly mediated histone (H3K27me3) methylation and DNA stimulated human prostate cancer cells to proliferate, migrate, methyltransferase–mediated DNA methylation suppress and invade, and inhibition of NE in vivo attenuated xenograft SERPINB1 expression in prostate cancer cells. Analysis of growth. Interestingly, reduced expression of SERPINB1, an The Cancer Genome Atlas and pyrosequencing demonstrate endogenous NE inhibitor, also correlates with diminished hypermethylation of the SERPINB1 promoter in prostate survival in some cancers. Therefore, we sought to characterize cancer compared with normal tissue, and the extent of pro- the role of SERPINB1 in prostate cancer. We find that SER- moter methylation negatively correlates with SERPINB1 PINB1 expression is reduced in human metastatic and locally mRNA expression.
    [Show full text]
  • Pediatric Primitive Neuroectodermal Tumors of the Central Nervous System Differentially Express Granzyme Inhibitors
    RESEARCH ARTICLE Pediatric Primitive Neuroectodermal Tumors of the Central Nervous System Differentially Express Granzyme Inhibitors Jeroen F. Vermeulen1, Wim van Hecke1, Wim G. M. Spliet1, José Villacorta Hidalgo3, Paul Fisch3, Roel Broekhuizen1, Niels Bovenschen1,2* 1 Department of Pathology, University Medical Center Utrecht, 3584CX, Utrecht, The Netherlands, 2 Laboratory of Translational Immunology, University Medical Center Utrecht, 3584CX, Utrecht, The Netherlands, 3 Institute of Pathology, University Medical Center Freiburg, 79106, Freiburg, Germany * [email protected] Abstract Background OPEN ACCESS Central nervous system (CNS) primitive neuroectodermal tumors (PNETs) are malignant Citation: Vermeulen JF, van Hecke W, Spliet WGM, primary brain tumors that occur in young infants. Using current standard therapy, up to 80% Villacorta Hidalgo J, Fisch P, Broekhuizen R, et al. of the children still dies from recurrent disease. Cellular immunotherapy might be key to (2016) Pediatric Primitive Neuroectodermal Tumors improve overall survival. To achieve efficient killing of tumor cells, however, immunotherapy of the Central Nervous System Differentially Express Granzyme Inhibitors. PLoS ONE 11(3): e0151465. has to overcome cancer-associated strategies to evade the cytotoxic immune response. doi:10.1371/journal.pone.0151465 Whether CNS-PNETs can evade the immune response remains unknown. Editor: Javier S Castresana, University of Navarra, SPAIN Methods Received: September 3, 2015 We examined by immunohistochemistry the immune response and immune evasion strate- Accepted: February 29, 2016 gies in pediatric CNS-PNETs. Published: March 10, 2016 Copyright: © 2016 Vermeulen et al. This is an open Results access article distributed under the terms of the Creative Commons Attribution License, which permits Here, we show that CD4+, CD8+, γδ-T-cells, and Tregs can infiltrate pediatric CNS-PNETs, unrestricted use, distribution, and reproduction in any although the activation status of cytotoxic cells is variable.
    [Show full text]
  • Serpinb2 Is Involved in Cellular Response Upon UV Irradiation
    www.nature.com/scientificreports OPEN SerpinB2 is involved in cellular response upon UV irradiation Hajnalka Majoros1, Zsuzsanna Ujfaludi1, Barbara Nikolett Borsos1, Viktória Vivien Hudacsek1, Zita Nagy3, Frederic Coin3, Krisztina Buzas2, Ilona Kovács4, Tamás Bíró5,6, Imre Miklós Boros1,2 1 Received: 20 August 2018 & Tibor Pankotai Accepted: 10 December 2018 Ultraviolet light induced pyrimidine dimer is a helix distortion DNA damage type, which recruits repair Published: xx xx xxxx complexes. However, proteins of these complexes that take part in both DNA damage recognition and repair have been well-described, the regulation of the downstream steps of nucleotide excision repair (NER) have not been clearly clarifed yet. In a high-throughput screen, we identifed SerpinB2 (SPB2) as one of the most dramatically upregulated gene in keratinocytes following UV irradiation. We found that both the mRNA and the protein levels of SPB2 were increased upon UV irradiation in various cell lines. Additionally, UV damage induced translocation of SPB2 from the cytoplasm to the nucleus as well as the damage induced foci formation of it. Here we show that SPB2 co-localizes with XPB involved in the NER pathway at UV-induced repair foci. Finally, we demonstrated that UV irradiation promoted the association of SPB2 with ubiquitylated proteins. In basal cell carcinoma tumour cells, we identifed changes in the subcellular localization of SPB2. Based on our results, we conclude that SPB2 protein has a novel role in UV-induced NER pathway, since it regulates the removal of the repair complex from the damaged site leading to cancerous malformation. Our genome is constantly exposed to endogenous and exogenous sources leading to DNA damage and impair- ment of genome integrity.
    [Show full text]
  • Low P66shc with High Serpinb3 Levels Favors Necroptosis and Better Survival in Hepatocellular Carcinoma
    biology Article Low P66shc with High SerpinB3 Levels Favors Necroptosis and Better Survival in Hepatocellular Carcinoma Silvano Fasolato 1, Mariagrazia Ruvoletto 1 , Giorgia Nardo 2, Andrea Rasola 3, Marco Sciacovelli 3, Giacomo Zanus 4,5, Cristian Turato 6 , Santina Quarta 1 , Liliana Terrin 1, Gian Paolo Fadini 1 , Giulio Ceolotto 1, Maria Guido 1, Umberto Cillo 4,7, Stefano Indraccolo 2,4, Paolo Bernardi 3 and Patrizia Pontisso 1,* 1 Department of Medicine, University of Padua, Via Giustiniani, 2, 35128 Padua, Italy; [email protected] (S.F.); [email protected] (M.R.); [email protected] (S.Q.); [email protected] (L.T.); [email protected] (G.P.F.); [email protected] (G.C.); [email protected] (M.G.) 2 Istituto Oncologico Veneto IOV- IRCCS, 35128 Padua, Italy; [email protected] (G.N.); [email protected] (S.I.) 3 Department of Biomedical Sciences, University of Padua, 35131 Padua, Italy; [email protected] (A.R.); [email protected] (M.S.); [email protected] (P.B.) 4 Department of Surgical, Oncological and Gastroenterological Sciences-DISCOG, University of Padua, 35128 Padua, Italy; [email protected] (G.Z.); [email protected] (U.C.); [email protected] (S.I) 5 Hepatobiliary and Pancreatic Surgery Unit-Treviso Hospital, 31100 Treviso, Italy 6 Department of Molecular Medicine, University of Pavia, 27100 Pavia, Italy; [email protected] 7 Unit of Hepatobiliary Surgery and Liver Transplantation, Padua University Hospital, 35128 Padua, Italy * Correspondence: [email protected]; Tel.: +39-049-821-7872; Fax: +39-049-875-4179 Citation: Fasolato, S.; Ruvoletto, M.; Simple Summary: Cell proliferation and escape from apoptosis are important pathological features Nardo, G.; Rasola, A.; Sciacovelli, M.; of hepatocellular carcinoma, one of the tumors with the highest mortality rate worldwide.
    [Show full text]
  • SERPINB3/4 Polyclonal Antibody
    PRODUCT DATA SHEET Bioworld Technology,Inc. SERPINB3/4 polyclonal antibody Catalog: BS60990 Host: Rabbit Reactivity: Human,Mouse,Rat BackGround: Swiss-Prot: Metastasis of a primary tumor to a distant site is deter- P29508/P48594 mined through signaling cascades that break down inter- Purification&Purity: actions between the cell and extracellular matrix proteins. The antibody was affinity-purified from rabbit antiserum Among the proteins mediating metastasis are serine by affinity-chromatography using epitope-specific im- prote-ases, such as neutrophil elastase. In 1985, Dr. Jim munogen and the purity is > 95% (by SDS-PAGE). Travis and Dr. R.W. Carrell designated an emerging fam- Applications: ily of serine protease inhibitors as the serpin fam-ily, WB: 1:500~1:1000 which share homology in both primary amino acid se- Storage&Stability: quence and tertiary structure. Serpins contain a stretch of Store at 4°C short term. Aliquot and store at -20°C long peptide that mimics a true substrate for a corresponding term. Avoid freeze-thaw cycles. serine protease. Serine proteases bind to this substrate Specificity: mimic in a 1:1 stoichiometric fashion and become cata- SERPINB3/4 polyclonal antibody detects endogenous lytically inactive. Aberrant ex-pression of serpin family levels of SERPINB3/4 protein. members can contribute to a number of conditions, in- DATA: cluding emphysema (a-1 antitrypsin deficiency), fatal bleeding (elastase to thrombin specificity) and thrombosis (antithrombin deficiency), and are indicators of cancer stage phenotypes (circulating levels of squamous cell car- cinoma antigen, known as SCCA1, increase in advancing stages of some cervical, lung, esophageal and head and neck cancers).
    [Show full text]
  • Tissue-Type Plasminogen Activator Is a Target of the Tumor Suppressor Gene Maspin
    Proc. Natl. Acad. Sci. USA Vol. 95, pp. 499–504, January 1998 Biochemistry Tissue-type plasminogen activator is a target of the tumor suppressor gene maspin SHIJIE SHENG*†,BINH TRUONG*, DEREK FREDRICKSON*, RUILIAN WU*, ARTHUR B. PARDEE‡, AND RUTH SAGER* *Division of Cancer Genetics and ‡Division of Cell Growth and Regulation, Dana–Farber Cancer Institute, Harvard Medical School, 44 Binney Street, Boston, MA 02115 Contributed by Arthur B. Pardee, November 10, 1997§ ABSTRACT The maspin protein has tumor suppressor that PAI-1 also inhibits cell motility via an integrin-mediated activity in breast and prostate cancers. It inhibits cell motility pathway by its interaction with cell surface-bound uPA and and invasion in vitro and tumor growth and metastasis in nude vitronectin (8, 9). mice. Maspin is structurally a member of the serpin (serine The RSL of maspin is shorter than that of other serpins (1), protease inhibitors) superfamily but deviates somewhat from casting doubt on its ability to act as a classical inhibitory serpin. classical serpins. We find that single-chain tissue plasmino- Pemberton et al. (10) reported that purified rMaspin(i) is a gen activator (sctPA) specifically interacts with the maspin substrate instead of an inhibitor to an array of serine proteases, reactive site loop peptide and forms a stable complex with including uPA and tissue-type plasminogen activator (tPA). recombinant maspin [rMaspin(i)]. Major effects of rMas- However, our evidence that the RSL is crucial for the biolog- pin(i) are observed on plasminogen activation by sctPA. First, ical activity of maspin would be consistent with maspin acting rMaspin(i) activates free sctPA.
    [Show full text]
  • Differential Gene Expression of Serine Protease Inhibitors in Bovine
    Hayashi et al. Reproductive Biology and Endocrinology 2011, 9:72 http://www.rbej.com/content/9/1/72 RESEARCH Open Access Differential gene expression of serine protease inhibitors in bovine ovarian follicle: possible involvement in follicular growth and atresia Ken-Go Hayashi, Koichi Ushizawa, Misa Hosoe and Toru Takahashi* Abstract Background: SERPINs (serine protease inhibitors) regulate proteases involving fibrinolysis, coagulation, inflammation, cell mobility, cellular differentiation and apoptosis. This study aimed to investigate differentially expressed genes of members of the SERPIN superfamily between healthy and atretic follicles using a combination of microarray and quantitative real-time PCR (QPCR) analysis. In addition, we further determined mRNA and protein localization of identified SERPINs in estradiol (E2)-active and E2-inactive follicles by in situ hybridization and immunohistochemistry. Methods: We performed microarray analysis of healthy (10.7 +/- 0.7 mm) and atretic (7.8 +/- 0.2 mm) follicles using a custom-made bovine oligonucleotide microarray to screen differentially expressed genes encoding SERPIN superfamily members between groups. The expression profiles of six identified SERPIN genes were further confirmed by QPCR analysis. In addition, mRNA and protein localization of four SERPINs was investigated in E2- active and E2-inactive follicles using in situ hybridization and immunohistochemistry. Results: We have identified 11 SERPIN genes expressed in healthy and atretic follicles by microarray analysis. QPCR analysis confirmed that mRNA expression of four SERPINs (SERPINA5, SERPINB6, SERPINE2 and SERPINF2) was greater in healthy than in atretic follicles, while two SERPINs (SERPINE1 and SERPING1) had greater expression in atretic than in healthy follicles. In situ hybridization showed that SERPINA5, SERPINB6 and SERPINF2 mRNA were localized in GCs of E2-active follicles and weakly expressed in GCs of E2-inactive follicles.
    [Show full text]